Media headlines about Capnia (NASDAQ:SLNO) have trended somewhat positive on Thursday, according to Accern Sentiment Analysis. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Capnia earned a media sentiment score of 0.19 on Accern’s scale. Accern also gave news stories about the company an impact score of 46.6941481752719 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Several research firms have commented on SLNO. Maxim Group set a $25.00 price objective on shares of Capnia and gave the company a “buy” rating in a report on Monday, August 14th. ValuEngine upgraded shares of Capnia from a “strong sell” rating to a “sell” rating in a report on Friday, October 6th. Finally, decreased their price objective on shares of Capnia from $25.00 to $8.00 and set a “buy” rating on the stock in a report on Wednesday, November 15th.

Capnia (NASDAQ SLNO) traded up $0.02 during trading hours on Thursday, hitting $1.41. 22,300 shares of the company’s stock traded hands, compared to its average volume of 24,733. Capnia has a 12-month low of $1.32 and a 12-month high of $6.60.

COPYRIGHT VIOLATION WARNING: This story was published by Daily Political and is the property of of Daily Political. If you are accessing this story on another website, it was copied illegally and republished in violation of US & international copyright law. The original version of this story can be read at

Capnia Company Profile

Soleno Therapeutics, Inc, formerly Capnia, Inc, is a healthcare company that develops and commercializes neonatology devices and diagnostics. The Company also has a therapeutics platform based on its proprietary technology for precision metering of gas flow. The Company offers products, such as CoSense end-tidal carbon monoxide (ETCO) Monitor, NeoPIP Infant Resuscitator and Accessories, and Serenz Nasal Relief.

Insider Buying and Selling by Quarter for Capnia (NASDAQ:SLNO)

Receive News & Ratings for Capnia Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Capnia Inc. and related companies with's FREE daily email newsletter.